Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer

Background:  Altered glycosylation of glycoconjugates is among the important molecular changes that accompany malignant transformation. The purpose of our study was to investigate clinical usefulness of circulatory levels of total and lipid bound sialic acid for early diagnosis and management of ora...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oral pathology & medicine Vol. 34; no. 5; pp. 263 - 267
Main Authors: RAJPURA, Kinnari B, PATEL, Prabhudas S, CHAWDA, Jyoti G, SHAH, Raksha M
Format: Journal Article
Language:English
Published: Oxford, UK Munksgaard International Publishers 01-05-2005
Blackwell
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:  Altered glycosylation of glycoconjugates is among the important molecular changes that accompany malignant transformation. The purpose of our study was to investigate clinical usefulness of circulatory levels of total and lipid bound sialic acid for early diagnosis and management of oral cavity cancer patients. Methods:  Blood samples were collected from 41 untreated oral cancer patients, 20 patients with oral pre‐cancerous conditions (OPC) and 20 healthy subjects. Serum sialic acid (total and lipid bound) levels were measured spectrophotometrically. Results:  Serum levels of total and lipid bound sialic acid were significantly elevated (P < 0.001) in untreated oral cancer patients as compared to healthy individuals as well as patients with OPC. Multivariate analysis documented that the progressive rise in total and lipid bound sialic acid was significantly associated (P = 0.0001 and 0.039, respectively) with stage of malignant disease. Conclusion:  The data revealed significant elevations in sialic acid levels in oral cancer patients and suggested potential utility of these parameters in diagnosis as well as determining clinical stage of the malignant disease.
Bibliography:ark:/67375/WNG-ZC3XJSZN-H
ArticleID:JOP210
istex:58DC114EC9B1A78AFA48F1794183A63D7620701C
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0904-2512
1600-0714
DOI:10.1111/j.1600-0714.2004.00210.x